Company intelligence / Profile preview

Embleema Global Health Consortium

Metuchen, New Jersey, United States
Ownership
Private
Employees
~29
Development stage
Other
01

Overview

Embleema is a healthcare technology company that provides a regulatory-grade health data platform designed to accelerate the development of precision medicines. The company's platform, which includes the HIVE bioinformatics system used by the FDA, unifies clinical, molecular, and real-world data to generate evidence for regulatory reviews. Embleema utilizes blockchain technology to manage patient consent and data sovereignty, allowing patients to securely share their medical records with researchers and life sciences companies. By streamlining data collection and analysis, Embleema helps pharmaceutical companies and research institutions conduct more efficient clinical trials and real-world evidence studies.

Therapeutic areas
OncologyNeurologyRare DiseasesInfectious Diseases
Modalities
Cell therapyGene therapyBiologicSmall moleculemRNA-based drugs
Industry
Biomedical IT and Biomedical Data Platforms
02

Partnerships

U.S. Food and Drug Administration (FDA)Clinical Data Interchange Standards Consortium (CDISC)Pierre FabreCALYM Carnot InstituteGeorge Washington UniversityTemple UniversityGustave RoussyJohnson & JohnsonEquasens (formerly Pharmagest)

Beyond the preview

Go deeper on Embleema Global Health Consortium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Embleema Global Health Consortium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call